SCHEMBL1999864

SCHEMBL1999864

Cc1nn(-c2ccc(-c3ccccc3)cc2)c(-c2ccccc2)c1CCO

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 3/20 0.50
CYP2C19 P33261 3/20 0.50
CYP1A2 P05177 2/20 0.50
NPC1 O15118 4/20 0.45
RAB9A P51151 4/20 0.45
HSD17B10 Q99714 2/20 0.44
KMT2A Q03164 2/20 0.44
TSHR P16473 2/20 0.44
TP53 P04637 2/20 0.44
MAPT P10636 2/20 0.44
CYP3A4 P08684 2/20 0.44
HIF1A Q16665 2/20 0.44
NPSR1 Q6W5P4 2/20 0.44
KDM4E B2RXH2 1/20 0.44
GMNN O75496 1/20 0.44
USP2 O75604 1/20 0.44
LMNA P02545 1/20 0.44
ESR1 P03372 1/20 0.44
CYP2D6 P10635 1/20 0.44
ALOX15 P16050 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11247967 0.82 CYP2C9 (0.56) CYP2C9CYP2C19CYP1A2NPC1RAB9A
SCHEMBL1997120 0.77 ALDH1A1 (0.53) CYP2C9CYP2C19CYP1A2HSD17B10KMT2A
SCHEMBL1195159 0.75 CYP2C9 (0.62) CYP2C9CYP2C19CYP1A2NPC1RAB9A
SCHEMBL11242627 0.73 CYP1A2 (0.52) CYP2C9CYP2C19CYP1A2NPC1RAB9A
SCHEMBL5209503 0.72 ALDH1A1 (0.43) CYP2C9CYP2C19CYP1A2NPC1RAB9A
SCHEMBL8512906 0.71 NPC1 (0.62) NPC1RAB9AKMT2ATSHRMEN1
SCHEMBL5206995 0.71 SMO (0.58) KMT2ANPSR1LMNAALDH1A1MEN1
SCHEMBL6098575 0.70 CYP1A2 (0.53) CYP1A2NPC1RAB9ATP53MAPT
SCHEMBL11252577 0.70 CYP1A2 (0.52) CYP2C9CYP2C19CYP1A2NPC1RAB9A
SCHEMBL14495717 0.70 CYP2C19 (0.64) CYP2C9CYP2C19CYP1A2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7960413-B2 Pyrazole compounds MERCK PATENT GMBH (DE) 2011-06-14 US disclosed
EP-1611094-B1 PYRAZOLE COMPOUNDS MERCK PATENT GMBH (DE) 2007-06-20 EP disclosed
US-20060276650-A1 Pyrazole compounds MERCK PATENT GMBH (DE) 2006-12-07 US disclosed
EP-1611094-A1 PYRAZOLE COMPOUNDS MERCK PATENT GmbH (DE) 2006-01-04 EP disclosed
WO-2004089888-A1 PYRAZOLE COMPOUNDS MERCK PATENT GMBH (DE) 2004-10-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276650-A1 Pyrazole compounds HTR1D, HTR1A, HTR3A CYP2C9 319/4885CYP2C19 189/4885CYP1A2 264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.